aloftace logo

aloftace logo

  • Home
  • About Us
    • About Us
    • Sustainability
    默认图片
  • Products
    • OEAI Health Risk Detector
    • AI Software Customization
    • Handheld Ultrasound
    默认图片
  • News & Events
    • News & Events
    • Industry Solutions
    默认图片
  • Contact Us
INQUIRY
SEARCH WHAT YOU WANT
English
  • English
oeai health detector

oeai health detector

NEWS & EVENTS
Home / News & Events / News & Events / EU EUDAMED Database to Be Mandatory in May 2026, AloftAce Takes the Lead in Completing Core Compliance Testing, and European Market Channel Investment Promotion Is Fully Launched

EU EUDAMED Database to Be Mandatory in May 2026, AloftAce Takes the Lead in Completing Core Compliance Testing, and European Market Channel Investment Promotion Is Fully Launched

oeai news and events 02
Previous: 2026 Global Commercial Health Detection Equipment Market Exceeds USD 7.4 Billion, AI Intelligent Devices Become Core Outlet for Channel Investment Promotion
Next: AloftAce Releases 2026 Global Channel Investment Promotion Support Plan, Providing Full-Chain Landing Support for Overseas Partners
SITE MAP
Home
About Us
Products
SITE MAP
Contact Us
News & Events
Industry Solutions
GLOBAL AGENCY RECRUITMENT
*Name
Company
*Email
WhatsApp
Message
CONTACT US

  • info@aloftace.com

  • WhatsApp

3/F, 3 Kehui 2nd St, Huangpu, Guangzhou Province, Guangdong, China.
info@aloftace.com
+86 400 1887291
AloftAce Medical Technology Co.,Ltd.
Copyright ©2026 AloftAce Medical Technology Co.,Ltd.
Privacy Policy
Terms and Conditions
Powered by iglobalwin.com